Nick Leschly 2seventy Bio, Inc. (TSVT) insider trading activity

Nick Leschly is President and CEO of 2seventy bio, Inc.. Currently has a direct ownership of 1.32 Million shares of TSVT, which is worth approximately $5.9 Million. The most recent transaction as insider was on Jan 08, 2024, when has been sold 235,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.32M

0% 3M change

26.46% 12M change

Total Value Held $5.9 Million

Nick Leschly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2024	BUY Grant, award, or other acquisition	-	235,000 Added 15.11%	1,320,476 Common Stock
Jan 05 2024	SELL Open market or private sale	$5,827 $3.75 p/Share	1,554 Reduced 0.14%	1,085,476 Common Stock
Jan 03 2024	SELL Open market or private sale	$279,847 $3.87 p/Share	72,312 Reduced 6.24%	1,087,030 Common Stock
Aug 22 2023	SELL Open market or private sale	$51,122 $5.49 p/Share	9,312 Reduced 0.8%	1,159,342 Common Stock
Aug 03 2023	SELL Open market or private sale	$55,537 $6.13 p/Share	9,060 Reduced 0.77%	1,168,654 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	509,821 Added 32.81%	1,044,214 Common Stock
Jan 12 2023	SELL Open market or private sale	$68,900 $10.46 p/Share	6,587 Reduced 1.21%	536,419 Common Stock

Jan 11 2023	SELL Open market or private sale	$21,536 $10.63 p/Share	2,026 Reduced 0.38%	534,393 Common Stock
Jan 09 2023	SELL Open market or private sale	$30,773 $10.33 p/Share	2,979 Reduced 0.55%	543,006 Common Stock
Aug 05 2022	SELL Open market or private sale	$89,249 $16.23 p/Share	5,499 Reduced 1.0%	545,985 Common Stock
Jul 15 2022	SELL Open market or private sale	$74,629 $13.81 p/Share	5,404 Reduced 0.97%	551,484 Common Stock
Mar 17 2022	BUY Grant, award, or other acquisition	$4,500,055 $12.2 p/Share	368,857 Added 39.84%	556,888 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	133,500 Added 16.2%	690,388 Common Stock
Jan 07 2022	SELL Open market or private sale	$78,186 $23.91 p/Share	3,270 Reduced 1.71%	188,031 Common Stock
Nov 11 2021	BUY Grant, award, or other acquisition	-	109,616 Added 36.43%	191,301 Common Stock

Also insider at

BLUE

bluebird bio, Inc. Healthcare

SYBX

SYNLOGIC, INC. Healthcare

Nick Leschly

President and CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSVT shares.

Notify only if

Value

Insider Trading

Get notified when an 2seventy Bio, Inc. insider buys or sells TSVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to 2seventy bio, Inc.

Track Activities on TSVT

Account